When GSK span out its consumer healthcare division as Haleon, in July 2022, it made financial headlines as the biggest European flotation in a decade. Behind the excitement in financial markets, though, the work was just beginning on building a new company culture.
The business had to change its corporate mindset to reflect the move away from being the consumer arm of one of the largest pharmaceutical corporations in the world, to a more agile business focused on understanding and meeting customer needs.
Through owning many household names – including Panadol, Voltarol, Advil and Sensodyne – the business is at...